BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The company will use the net proceeds from the offering to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Public Offering
BioSig Technologies plans to offer shares of common stock through an underwritten public offering.
Net Proceeds
The net proceeds will be used to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are joint book-running managers of the offering.
- The completion of the offering remains subject to market conditions, with uncertainties regarding timing, size, or terms.
- Interested parties should read the preliminary prospectus supplement and other documents for detailed information before investing.
BioSig Technologies' announcement of the proposed public offering signifies a strategic move to raise funds for future investments and operations, with a focus on gold bullion and general corporate purposes.